Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis

Meta-analysis of circulating HPV cDNA in blood as a biomarker for cervical cancer.

PLoS OnePubMed 32027658DOI 10.1371/journal.pone.0224001